PubRank

A Zeevi

Author PubWeight™ 188.93‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet 1994 5.54
2 Baboon-to-human liver transplantation. Lancet 1993 4.01
3 Systemic chimerism in human female recipients of male livers. Lancet 1992 3.63
4 Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010 3.29
5 Renal transplantation in baboons under FK 506. Surgery 1989 3.17
6 Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation 1993 3.13
7 Functional characterization of infiltrating T lymphocytes in human hepatic allografts. Hum Immunol 1986 2.84
8 Allospecificity of activated T cells grown from endomyocardial biopsies from heart transplant patients. Transplantation 1986 2.82
9 Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA. Am J Transplant 2013 2.45
10 Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level? Am J Transplant 2015 2.24
11 A critical appraisal of methods to grade transplant glomerulitis in renal allograft biopsies. Am J Transplant 2010 2.14
12 Specificity of alloactivated human T lymphocyte clones in secondary proliferation, cell-mediated lympholysis and interleukin-2 release. J Immunogenet 1985 1.82
13 Interactions between bronchoalveolar lymphocytes and macrophages in heart-lung transplant recipients. Hum Immunol 1985 1.65
14 Weaning of immunosuppression in long-term liver transplant recipients. Transplantation 1995 1.59
15 Stimulation and inhibition of human T-lymphocyte colony cell proliferation by hemopoietic cell factors. Cell Immunol 1977 1.58
16 FK-506 enhances cyclosporine uptake by peripheral blood lymphocytes. Transplant Proc 1987 1.56
17 Large airway inflammation in heart-lung transplant recipients--its significance and prognostic implications. Transplantation 1990 1.51
18 Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management. J Thorac Cardiovasc Surg 1995 1.48
19 Multivisceral intestinal transplantation: surgical pathology. Pediatr Pathol 1989 1.45
20 Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption. Am J Pathol 1997 1.41
21 Ciprofloxacin does not block the antiproliferative effect of tacrolimus. Transplantation 1997 1.39
22 FK 506 as a growth control factor. Transplant Proc 1990 1.36
23 Contribution of naïve and memory T-cell populations to the human alloimmune response. Am J Transplant 2009 1.34
24 Spontaneous and iatrogenically augmented leukocyte chimerism in organ transplant recipients. Transplant Proc 1994 1.29
25 Mode of action of tacrolimus (FK506): molecular and cellular mechanisms. Ther Drug Monit 1995 1.28
26 Excretion of cyclosporine and its metabolites in human bile. Transplant Proc 1986 1.27
27 Alloreactive T-cell recognition of two DQ beta allelic specificities associated with DQw1. Hum Immunol 1987 1.26
28 Augmentation of chimerism in whole organ recipients by simultaneous infusion of donor bone marrow cells. Transplant Proc 1995 1.24
29 Heart-lung transplantation: lessons learned and future hopes. Ann Thorac Surg 1987 1.23
30 Dynamics of allospecific T lymphocyte infiltration in vascularized human allografts. Immunol Res 1986 1.20
31 Serological and cellular definition of a new HLA-DR associated determinant, MC1, and its association with rheumatoid arthritis. Hum Immunol 1984 1.19
32 Combined kidney/bone marrow transplantation--evidence of augmentation of chimerism. Transplantation 1995 1.19
33 Practical aspects of FK 506 analysis (Pittsburgh experience). Transplant Proc 1991 1.19
34 FK 506, rapamycin, and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line. Transplant Proc 1991 1.15
35 Studies on mechanisms of augmentation of liver regeneration by cyclosporine and FK 506. Hepatology 1991 1.13
36 Immunosuppressive properties of thalidomide. Inhibition of in vitro lymphocyte proliferation alone and in combination with cyclosporine or FK506. Transplantation 1991 1.10
37 Allospecific CD154+ T cells associate with rejection risk after pediatric liver transplantation. Am J Transplant 2008 1.10
38 Frequent achievement of a drug-free state after orthotopic liver transplantation. Transplant Proc 1993 1.08
39 IMPDH1 gene polymorphisms and association with acute rejection in renal transplant patients. Clin Pharmacol Ther 2007 1.07
40 T-lymphocyte colony growth in vitro: factors modulating clonal expansion. Immunol Rev 1981 1.07
41 Augmentation of chimerism with perioperative donor bone marrow infusion in organ transplant recipients: a 44 month follow-up. Transplant Proc 1997 1.07
42 Association of PLT specificity of alloreactive lymphocyte clones with HLA-DR, MB and MT determinants. Immunogenetics 1982 1.04
43 Long-term culture of viable human pancreatic islets in pyruvate-rich medium. Transplant Proc 1995 1.04
44 Voriconazole prophylaxis in lung transplant recipients. Am J Transplant 2006 1.04
45 Combined bone marrow and whole organ transplantation from the same donor. Transplant Proc 1994 1.02
46 C4d deposition in lung allografts is associated with circulating anti-HLA alloantibody. Transpl Immunol 2005 1.00
47 Upregulation of messenger RNA for inflammatory cytokines in middle ear mucosa in a rat model of acute otitis media. Ann Otol Rhinol Laryngol 1998 1.00
48 Concomitant infusion of unmodified donor bone marrow into unconditioned recipients of intestinal allografts. Transplant Proc 1996 1.00
49 Analysis of T lymphocytes infiltrating human hepatic allografts. Transplant Proc 1987 1.00
50 Increased lymphocyte adherence to human arterial endothelial cell monolayers in the context of allorecognition. J Immunol 1990 1.00
51 Immunologically mediated disease of the airways after pulmonary transplantation. Ann Surg 1988 1.00
52 Forward and reverse selection for longevity in Drosophila is characterized by alteration of antioxidant gene expression and oxidative damage patterns. Exp Gerontol 2000 1.00
53 Weaning of immunosuppression in long-term recipients of living related renal transplants: a preliminary study. Transplant Proc 1995 0.99
54 Perioperative donor bone marrow infusion augments chimerism in heart and lung transplant recipients. Ann Thorac Surg 1995 0.98
55 Combined simultaneous kidney/bone marrow transplantation. Transplantation 1995 0.98
56 Two hundred living donor kidney transplantations under alemtuzumab induction and tacrolimus monotherapy: 3-year follow-up. Am J Transplant 2008 0.98
57 Preformed and de novo donor specific antibodies in visceral transplantation: long-term outcome with special reference to the liver. Am J Transplant 2012 0.97
58 Propagation and characterization of lymphocytes from transplant biopsies. Crit Rev Immunol 1991 0.97
59 Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes. Hepatology 1991 0.96
60 14th International HLA and Immunogenetics Workshop: report on the Prospective Chronic Rejection Project. Tissue Antigens 2007 0.95
61 Lymphocyte growth from cardiac allograft biopsy specimens with no or minimal cellular infiltrates: association with subsequent rejection episode. J Heart Transplant 1989 0.95
62 Aerosolized cyclosporine in lung recipients with refractory chronic rejection. Am J Respir Crit Care Med 1996 0.93
63 Interleukin 6 and interferon-gamma gene expression in lung transplant recipients with refractory acute cellular rejection: implications for monitoring and inhibition by treatment with aerosolized cyclosporine. Transplantation 1997 0.93
64 Propagation of lymphocytes infiltrating human liver allografts. Correlation with histologic diagnosis of rejection. Transplantation 1990 0.93
65 Does histologic acute rejection in lung allografts predict the development of bronchiolitis obliterans? Transplantation 1991 0.93
66 Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans. Eur Respir J 2004 0.92
67 Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients. Transplantation 1997 0.92
68 Real-time monitoring of acute liver-allograft rejection using the Banff schema. Transplantation 2002 0.91
69 Interleukin-6, a marker of preservation injury in clinical lung transplantation. J Heart Lung Transplant 1993 0.90
70 Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients. Transplant Proc 1996 0.90
71 Preservation of post-transplant lung function with aerosol cyclosporin. Eur Respir J 2004 0.90
72 Dose-related reversal of acute lung rejection by aerosolized cyclosporine. Am J Respir Crit Care Med 1997 0.89
73 Lymphocytes of bronchoalveolar lavages from heart-lung transplant recipients. J Heart Transplant 1987 0.89
74 A clinical trial combining donor bone marrow infusion and heart transplantation: intermediate-term results. J Thorac Cardiovasc Surg 2000 0.89
75 Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA-drilling down on key sources of variation. Am J Transplant 2013 0.89
76 The epidemiology of parainfluenza virus infection in lung transplant recipients. Clin Infect Dis 2001 0.88
77 Steroid-free tacrolimus monotherapy after pretransplantation thymoglobulin or Campath and laparoscopy in living donor renal transplantation. Transplant Proc 2005 0.88
78 Re-examination of the lymphocytotoxic crossmatch in liver transplantation: can C4d stains help in monitoring? Am J Transplant 2011 0.88
79 Pulmonary arteriosclerosis in long-term human heart-lung transplant recipients. Transplantation 1989 0.87
80 Ex vivo generation of effective Epstein-Barr virus (EBV)-specific CD8+ cytotoxic T lymphocytes from the peripheral blood of immunocompetent Epstein Barr virus-seronegative individuals. Transplantation 2000 0.86
81 Adjuvant bone marrow infusion in clinical organ transplant recipients. Transplant Proc 1998 0.86
82 HLA antigen expression on cultured human arterial endothelial cells. Tissue Antigens 1988 0.86
83 Proliferative responses of bronchoalveolar lavage lymphocytes from heart-lung transplant patients. Transplantation 1990 0.86
84 ASHI Workshop Summary Report of the Science and Education Subcommittee: structural and functional relationships of human class II MHC molecules. Hum Immunol 1986 0.85
85 Aerosol cyclosporine prevents acute allograft rejection in experimental lung transplantation. J Thorac Cardiovasc Surg 1998 0.85
86 Identical longevity phenotypes are characterized by different patterns of gene expression and oxidative damage. Exp Gerontol 2000 0.85
87 Effects of FK 506 and cyclosporine on T-cell activation: integrin-mediated adhesion of T cells, proliferation, and maturation of cytotoxic T cells. Transplant Proc 1991 0.85
88 Infusion of donor leukocytes to induce tolerance in organ allograft recipients. J Leukoc Biol 1999 0.85
89 HLA-class II antigen expression in human heart-lung allografts. Transplantation 1990 0.84
90 Early tolerance in pediatric liver allograft recipients. J Pediatr Surg 1994 0.84
91 Mixed allogeneic chimerism in lung allograft recipients. Hum Pathol 1994 0.83
92 Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts. Circulation 1998 0.83
93 DQ alpha and beta RFLP reveals the composition of the DQ molecule recognized by T-cell clones. Immunogenetics 1986 0.83
94 Detection of non-HLA-DR determinants by alloreactive lymphocyte clones. Hum Immunol 1983 0.83
95 TGF-beta 1 pretreatment impairs the allostimulatory function of human bone marrow-derived antigen-presenting cells for both naive and primed T cells. Transpl Immunol 1996 0.83
96 Unexpectedly high incidence of Pneumocystis carinii infection after lung-heart transplantation. Implications for lung defense and allograft survival. Am Rev Respir Dis 1988 0.83
97 Partial purification and characterization of the human lymphocyte colony enhancing factor (LCEF). Immunology 1978 0.83
98 Adherence of alloreactive lymphocytes to human arterial endothelial cell monolayers. Clin Exp Immunol 1989 0.83
99 Species differences in sensitivity of T lymphocytes to immunosuppressive effects of FK 506. Transplantation 1990 0.83
100 HLA phenotype of lung lavage cells following heart-lung transplantation. J Heart Transplant 1987 0.83
101 Interferon-alpha affects the immune response in post-transplant lymphoproliferative disorder. Am J Respir Crit Care Med 1996 0.82
102 Treatment of refractory acute allograft rejection with aerosolized cyclosporine in lung transplant recipients. J Thorac Cardiovasc Surg 1997 0.82
103 An attempt to induce tolerance with infusion of donor bone marrow in organ allograft recipients. Adv Exp Med Biol 1997 0.82
104 Benefits of posttransplantation monitoring of interleukin 6 in lung transplantation. Ann Thorac Surg 1993 0.82
105 The immunosuppressant drug FK506 is a potent trophic agent for human fetal neurons. Brain Res Dev Brain Res 2001 0.82
106 Induction of graft acceptance after dog kidney or liver transplantation. Transplant Proc 1990 0.82
107 Radioreceptor assay for quantifying FK-506 immunosuppressant in whole blood. Clin Chem 1992 0.82
108 Serial monitoring of immunologic function and phenotype of lymphocytes in the blood of transplanted patients randomized to cyclosporine or FK 506. Transplant Proc 1991 0.82
109 Propagation of alloreactive lymphocytes from histologically negative endomyocardial biopsies from heart transplant patients. Association with subsequent histological evidence of allograft rejection. Transplantation 1989 0.82
110 Quantitation of immunosuppression by tacrolimus using flow cytometric analysis of interleukin-2 and interferon-gamma inhibition in CD8(-) and CD8(+) peripheral blood T cells. Ther Drug Monit 2001 0.81
111 Alemtuzumab pre-conditioning with tacrolimus monotherapy in pediatric renal transplantation. Am J Transplant 2007 0.81
112 Immunologic challenges in small bowel transplantation. Am J Transplant 2012 0.81
113 The effect of cytokine gene polymorphisms on pediatric heart allograft outcome. J Heart Lung Transplant 2001 0.81
114 14th International HLA and Immunogenetics Workshop Prospective Chronic Rejection Project: a three-year follow-up analysis. Clin Transpl 2007 0.81
115 Impact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia. Haemophilia 2010 0.81
116 1.7 year follow-up after bortezomib therapy for refractory antibody mediated rejection. Clin Transpl 2010 0.81
117 Sequential infiltration of class I and class II specific alloreactive T cells in human cardiac allografts. Transplant Proc 1987 0.81
118 IL-2-augmented primed-lymphocyte test responses of lymphocytes cultured from endomyocardial biopsies from heart transplant patients. Transplantation 1992 0.81
119 The impact of pharmacogenomic factors on steroid dependency in pediatric heart transplant patients using logistic regression analysis. Pediatr Transplant 2004 0.81
120 Monitoring of acute lung rejection and infection by bronchoalveolar lavage and plasma levels of hyaluronic acid in clinical lung transplantation. J Heart Lung Transplant 1995 0.81
121 Functional differences between cells from MLR colonies grown in soft agar cultures. J Immunol 1980 0.81
122 Rare-event analysis of circulating human dendritic cell subsets and their presumptive mouse counterparts. Transplantation 2001 0.80
123 The impact of pharmacogenomic factors on acute persistent rejection in adult lung transplant patients. Transpl Immunol 2004 0.80
124 Unopposed neutrophil elastase in bronchoalveolar lavage from transplant recipients with cystic fibrosis. Am J Respir Crit Care Med 1999 0.80
125 Cytokine mRNA profiles in Epstein-Barr virus-associated post-transplant lymphoproliferative disorders. Clin Transplant 1999 0.80
126 Effects of donor bone marrow infusion in clinical lung transplantation. Ann Thorac Surg 2000 0.80
127 Monitoring the patient off immunosuppression. Conceptual framework for a proposed tolerance assay study in liver transplant recipients. Transplantation 2001 0.79
128 Production of a glycosaminoglycan stimulatory factor by cloned human T lymphocytes activated in vitro. Arthritis Rheum 1986 0.79
129 Heat shock protein-induced T-lymphocyte propagation from endomyocardial biopsies in heart transplantation. J Heart Lung Transplant 1995 0.79
130 Interactions between endothelial cells and alloreactive T cells involved in allograft immunity. Transplant Proc 1988 0.79
131 Human leukocyte antigen-class II-positive human corneal epithelial cells activate allogeneic T cells. Invest Ophthalmol Vis Sci 1994 0.79
132 Reversal of graft-versus-host disease with infusion of autologous bone marrow. Cell Transplant 1994 0.79
133 Evidence for the presence of multilineage chimerism and progenitors of donor dendritic cells in the peripheral blood of bone marrow-augmented organ transplant recipients. Transplantation 1997 0.79
134 Stromal cell involvement in leukemogenesis and carcinogenesis. In Vivo 1996 0.79
135 Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts. Ann Transplant 1997 0.79
136 Effects of combined administration of FK 506 and the purine biosynthesis inhibitors mizoribine or mycophenolic acid on lymphocyte DNA synthesis and T cell activation molecule expression in human mixed lymphocyte cultures. Transpl Immunol 1993 0.79
137 Regulation of constitutive nitric oxide synthase activity by the human heart. Am J Cardiol 1995 0.79
138 Mitogen responses of lymphocytes from lung transplant recipients--correlation with rejection and infection. Transplantation 1992 0.79
139 Late onset cytomegalovirus disease in liver transplant recipients: de novo reactivation in recurrent hepatitis C virus hepatitis. Transpl Int 1998 0.78
140 Renal transplantation at the University of Pittsburgh: the impact of FK506. Clin Transpl 1994 0.78
141 Soluble donor HLA class I and beta 2m-free heavy chain in serum of lung transplant recipients: steady-state levels and increases in patients with recurrent CMV infection, acute rejection episodes, and poor outcome. Hum Immunol 2000 0.78
142 Primed lymphocyte testing specificity of alloreactive lymphocyte clones for HLA-B locus determinants. Proc Natl Acad Sci U S A 1983 0.78
143 The role of endogenous interleukin-2 in proliferation of human carcinoma cell lines. Br J Cancer 1999 0.78
144 Cytokine induction during cardiac surgery: analysis of TNF-alpha expression pre- and postcardiopulmonary bypass. J Card Surg 1995 0.78
145 Human bone marrow obtained from vertebral bodies: cell isolation, phenotyping, progenitor assay, and transplantation. Transplant Proc 1994 0.78
146 Mitogen responses and T4/T8 ratios in asymptomatic hemophiliac patients. Transfusion 1985 0.78
147 Effects of FK 506, mycophenolic acid, and bredinin on OKT-3-, PMA-, and alloantigen-induced activation molecule expression on cultured CD4+ and CD8+ human lymphocytes. Transplant Proc 1991 0.78
148 Enhancement of donor cell chimerism in whole organ allograft recipients by adjuvant bone marrow transplantation. Transplant Proc 1995 0.78
149 In vitro culture of B-lymphocytes derived from Epstein-Barr-virus-associated posttransplant lymphoproliferative disease: cytokine production and effect of interferon-alpha. In Vitro Cell Dev Biol Anim 1998 0.78
150 Effect of aminoguanidine and cyclosporine on lung allograft rejection. Ann Thorac Surg 1996 0.77
151 Use of autologous dendritic cells loaded with apoptotic LCL for ex vivo generation of specific CTL from the PBMC of EBV(-) individuals. Transplant Proc 2001 0.77
152 Heterogeneity of cytolytic and suppressor clones of alloactivated cells generated from soft agar colonies. Hum Immunol 1982 0.77
153 In vitro culture of infiltrating lymphocytes from coronary arteries and endomyocardial biopsies: association with graft coronary disease. Transplant Proc 1991 0.77
154 Efficacy of inhaled cyclosporine in lung transplant recipients with refractory rejection: correlation of intragraft cytokine gene expression with pulmonary function and histologic characteristics. Surgery 1995 0.77
155 Propagation of infiltrating lymphocytes and graft coronary disease in cardiac transplant recipients. Hum Immunol 1990 0.77
156 Human-to-baboon bone marrow transplantation after conditioning with nonlethal irradiation. Transplant Proc 1994 0.77
157 P-glycoprotein (P-gp) is upregulated in peripheral T-cell subsets from solid organ transplant recipients. J Clin Pharmacol 2001 0.77
158 Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus. Transplantation 2001 0.77
159 Long-term survival of rat cardiac allografts by intrathymic plus portal venous injections of donor bone marrow cells and short-term tacrolimus immunosuppression. Transpl Int 2001 0.77
160 Documentation in bone-marrow-augmented organ recipients of the presence of dendritic cell progenitors of donor origin. Transplant Proc 1997 0.77
161 In the lung aerosol cyclosporine provides a regional concentration advantage over intramuscular cyclosporine. J Heart Lung Transplant 2000 0.77
162 Immunogenetic analysis of the HLA-D region: serological and cellular detection of the MB system. Clin Immunol Immunopathol 1982 0.76
163 Propagation of lymphocytes from human heart transplant biopsies: methodologic considerations. Transplant Proc 1988 0.76
164 Pharmacogenomics and lung transplantation: clinical implications. Pharmacogenomics J 2006 0.76
165 Kidney transplantation with bone marrow augmentation: five-year outcomes. Transplant Proc 2001 0.76
166 Persistent lack of human herpesvirus-6 specific T-helper cell response in liver transplant recipients. Transpl Infect Dis 2002 0.76
167 Phenotypic and functional characteristics of colonic lymphocytes isolated from patients with primary sclerosing cholangitis and inflammatory bowel disease. Hepatogastroenterology 1995 0.76
168 Allospecificity of liver allograft-derived lymphocytes and correlation with clinicopathologic findings. Transplant Proc 1988 0.75
169 Experimental animal model of graft-versus-host disease (GVHD) after small-bowel transplantation: characteristics of the model and application to developing treatment strategies. Transplant Proc 1997 0.75
170 Presence of CD4, CD8 double-negative and T-cell receptor-gamma-delta-positive T cells in lymphocyte cultures propagated from coronary arteries from heart transplant patients with graft coronary disease. J Heart Lung Transplant 1992 0.75
171 Immune modulation in organ allograft recipients by single or multiple donor bone marrow infusions. Transplant Proc 1999 0.75
172 Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients. Transplant Proc 1997 0.75
173 Donor bone marrow infusion in liver recipients: effect on the occurrence of acute cellular rejection. Transplant Proc 2001 0.75
174 Cytokine profile in graft-versus-host disease after small bowel transplantation. Transplant Proc 1996 0.75
175 Effects of immunotherapy on experimental immunodeficiency-related lymphoproliferative disease. Transplantation 1998 0.75
176 Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction. J Heart Lung Transplant 1997 0.75
177 Phenotypic T-cell changes in thoracic transplant recipients immunosuppressed with FK 506. Transplant Proc 1991 0.75
178 Evidence for engraftment of human bone marrow cells in non-lethally irradiated baboons. Transplantation 1997 0.75
179 Perioperative donor bone marrow infusion in recipients of organ allografts. Transplant Proc 1997 0.75
180 Life in the allogeneic environment after lung transplantation. Lung 1990 0.75
181 Definition of HLA-DQ polymorphisms by RFLP and in serological and cellular assays. Transplant Proc 1987 0.75
182 Selective transport of Li+ across lipid bilayer membranes mediated by an ionophore of novel design (ETH1644). J Membr Biol 1985 0.75
183 Donor-specific cytotoxicity testing: an advance in detecting pulmonary allograft rejection. Ann Thorac Surg 1990 0.75
184 Bone marrow transplantation for severe aplastic anemia using a phenotypically HLA-identical, SB-compatible unrelated donor. Transplantation 1983 0.75
185 Immunologic consequences of transplantation. Chest Surg Clin N Am 1995 0.75
186 Improved long-term culture of functional human islets in serum-free medium. Transplant Proc 1994 0.75
187 Bronchoalveolar macrophage-lymphocyte reactivity in heart-lung transplant recipients. Transplant Proc 1987 0.75
188 Role of HLA in intragraft cellular immunity in human liver transplantation. Transplant Proc 1988 0.75
189 Morphologic and immunophenotypic characterization of a cell line derived from liver tissue with Epstein-Barr virus associated post-transplant lymphoproliferative disease. In Vitro Cell Dev Biol Anim 1994 0.75
190 Clinical relevance of in vitro propagation of activated lymphocytes from endomyocardial biopsy samples of pediatric heart transplant recipients. Pediatr Transplant 1998 0.75
191 A functional analysis of hematopoietic growth factor production from class I and class II human alloreactive T cell clones. Int J Cell Cloning 1988 0.75
192 Monoclonal versus polyclonal antibody therapy for prophylaxis against rejection after heart transplantation. J Heart Transplant 1990 0.75
193 T-helper cell responses in liver transplant recipients: correlation with cytomegalovirus and other major infections. Transpl Infect Dis 2004 0.75
194 Sterilization of human small intestine allograft biopsies for later immunologic studies. Transplantation 1991 0.75
195 Interleukin-10 production by a B-cell line derived from human post-transplant lymphoproliferative disease. Hematol Oncol 1995 0.75
196 Simultaneous solid organ, bone marrow, and islet allotransplantation in type I diabetic patients. Transplant Proc 1994 0.75
197 Diminished IL-10 production in subjects with allergy after infection with influenza A virus. J Allergy Clin Immunol 1999 0.75
198 Measurement of basal, substrate induced and total P-glycoprotein activity in bronchoalveolar lavage T-cell subsets. Cytometry A 2004 0.75
199 Functional studies of in vivo committed lymphocytes propagated from organ transplants. Prog Clin Biol Res 1986 0.75
200 Characterization of the biopsy growth assay in monitoring cardiac transplant patients for rejection. Transplant Proc 1993 0.75
201 Detection of HLA-DR associated PLT determinants by alloreactive lymphocyte clones. Immunogenetics 1983 0.75
202 Transfer of HLA antigens from stimulatory B cells to alloreactive T lymphocytes: a novel mechanism of "allospecific" autoregulation. Transplant Proc 1999 0.75
203 Heterogeneity of human T-lymphocyte clones generated from autologous mixed-lymphocyte cultures. Clin Immunol Immunopathol 1984 0.75
204 In vitro studies of endomyocardial biopsies from heart transplant recipients on RATG and OKT3 immunoprophylaxis protocols. Transplantation 1989 0.75
205 Inhibition of lymphoproliferation by middle ear effusion in experimental otitis media. Arch Otolaryngol Head Neck Surg 1992 0.75
206 Immunogenetic analysis of the HLA complex with alloreactive T cell clones. Hum Immunol 1983 0.75
207 Diminished lymphocyte growth from endomyocardial biopsies from cardiac transplant patients on FK 506 immunosuppression. Transplant Proc 1991 0.75
208 The immunosuppressive activity of the aldehydic transformation of cyclosporine on alloreactive T-cells. J Clin Pharmacol 1991 0.75
209 Dynamics of bronchoalveolar lavage in the canine lung transplant. Transplant Proc 1988 0.75
210 Sirolimus inhibition of lymphocyte proliferation is not antagonized by ciprofloxacin and other quinolone antibiotics. Transplant Proc 2001 0.75
211 Propagation and characterization of lymphocytes infiltrating livers of patients with primary biliary cirrhosis and autoimmune hepatitis. Hum Immunol 1990 0.75
212 Colony growth of T lymphocytes in vitro. Control and regulation of clonal formation. Acta Haematol 1979 0.75